PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $176,947,000 | +58.2% | 83,465,566 | 0.0% | 73.50% | +19.6% |
| Q2 2022 | $111,844,000 | -36.5% | 83,465,566 | 0.0% | 61.44% | -12.0% |
| Q1 2022 | $176,112,000 | -43.1% | 83,465,566 | +0.1% | 69.80% | -22.1% |
| Q4 2021 | $309,341,000 | -24.7% | 83,380,436 | +1.2% | 89.60% | +12.1% |
| Q3 2021 | $411,078,000 | -23.4% | 82,380,436 | +0.1% | 79.90% | +5.5% |
| Q2 2021 | $536,771,000 | -4.7% | 82,326,865 | +0.7% | 75.73% | -0.7% |
| Q1 2021 | $563,330,000 | -32.4% | 81,760,477 | +0.0% | 76.27% | +0.1% |
| Q4 2020 | $833,789,000 | +183.5% | 81,744,063 | -2.7% | 76.22% | +25.2% |
| Q3 2020 | $294,075,000 | -28.8% | 84,021,428 | +1.5% | 60.87% | -11.1% |
| Q2 2020 | $413,125,000 | +46.8% | 82,790,616 | 0.0% | 68.44% | +13.2% |
| Q1 2020 | $281,488,000 | – | 82,790,616 | – | 60.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |